ascites

1. In animal studies, this product can inhibit u27, s180 tumors, ehrlich ascites cells and relieve pain.
   本品对试验动物肿瘤瘤株u27、s180、抑制艾氏腹水癌，并有镇痛作用。
2. In this way, the membrane fluidity of living Ehrlich ascites tumor cells was determined.
   用此法测定了艾氏腹水癌细胞的膜流动性。
3. Objective To discuss diagnosis and treatment of pancreatic ascites.
   目的提高对胰性腹水的认识和诊治水平。
4. Objective: To explore the effect of exosomes from ascites of gastric cancer patients on the function of macrophage.
   目的：探讨胃癌患者腹水中分离的外泌体对外周血来源的巨噬细胞功能的影响。
5. Progress in the treatment of ascites due to cirrhosis.
   探讨肝硬化腹水治疗进展。
6. New medicines such as vasoconstrictors and V2-receptors of vasopressin maybe beneficial in patients with ascites in liver cirrhosis.
   新药（如V2受拮抗剂和血管收缩剂等）对肝硬化腹水的治疗可能带来希望。
7. Objective Toe value the effect of intracavity treatment with DDP and BRM for malignant pleural effusions or ascites.
   目的探讨顺铂（DDP）联合生物反应调节剂（BRM）治疗恶性胸腹腔积液的疗效。
8. Purpose: To evaluate the efficacy and tolerance of radiofrequency chemohyperthermia combined with intravenous chemotherapy form malignant ascites.
   目的：探讨射频热疗加腹腔热灌注化疗和静脉双途径化疗治疗恶性腹水的疗效和毒副反应。
9. Objective To study clinical curative effect of cirrhosis ascites treated with four drugs in combination.
   目的探讨四联疗法治疗肝硬化腹水的临床疗效。
10. There are probably several factors responsible for water and salt retention and ascites in hepatic disease.
    引起肝病患者水、盐潴留和腹水的原因可能不止一个。
11. Clinical research on ultrafiltration and intraperitoneal reinfusion of liver cancer intractable bloody ascites
    肝癌顽固性血性腹水超滤浓缩回输腹腔的临床研究
12. Spontaneous bacterial peritonitis Ascites Granulocyte colony stimulating factor C reactive protein;
    自发性腹膜炎；腹水；粒细胞集落刺激因子；C-反应蛋白；
13. Parenteral nutrition and laparoscopic therapy in chylous ascites
    肠外营养和腹腔镜下手术治疗乳糜性腹水
14. In this paper, the characteristics of the ascites, the procedure of diagnosis and treatment are discussed.
    本文主要就腹腔积液的特点以及临床诊治思维进行讨论。
15. Significance of DNA ploidy analysis and carcinoembryonic antigen assay for differential diagnosis between benign and malignant ascites
    DNA倍体分析与癌胚抗原检测对良、恶性腹水鉴别诊断的意义
16. Chylous ascites is an clinically infrequent disease.
    乳糜性腹水是一种极为少见的临床疾病。
17. ASCITES-Fluid accumulation around the liver and other abdominal organs resulting from portal hypertension.
    腹水&液体聚集在肝和其他内脏附近，是门脉高压的结果。
18. Ehrlich ascites tumor cell;
    艾氏腹水瘤细胞；
19. Nursing intervention and analysis of 183 hepatic cirrhosis patients complicated with ascites
    183例肝硬化腹水患者的护理干预与分析
20. If tumor spread into abdominal cavity and induced cancerous ascites.
    如果说是肿瘤扩散到腹腔引起的癌性腹水。
21. Conclusion: Chronic liver disease combined with hemorrhagic ascites would be a bad prognosis.
    结论慢性肝病并有自发性血性腹水的病人预后不良。
22. They then observed a small percentage of stem-like cells in human ovarian cancer lines and in cells taken from ascites fluid that had accumulated within the abdomen of several ovarian cancer patients.
    接着他们在人卵巢癌株和从腹水中取出的癌细胞中观察到很小比例的干细胞样细胞，腹水由取之数位卵巢癌患者的腹部积累而成。
23. Objective To evaluate the antitumor efficiency of IL-12 gene mediated by hydrodynamic injection in mouse models of malignant ascites.
    目的：应用水流动力学注射基因转移法转移白细胞介素12（IL-12）基因，观察其对小鼠恶性腹水的治疗效果。
24. Portal hypertension can lead to ascites, an accumulation of fluid that fills and distends the abdomen.
    门脉高压可以导致腹水，体液聚积，充满腹部。门脉高压有两种严重后果。
25. Objective: To explore the efficacy and practicality of the system of reinfusion of ascites fluid concentrate in treatment of patients who suffered from hepatocirrhosis with ascites.
    目的：对我院肝硬化合并顽固性腹水患者采用腹水超滤过浓缩回输系统治疗进行回顾性分析，了解该系统对肝硬化合并顽固性腹水患者的有效性和实用性。
26. Patients present ascites and obvious spleen enlargement.
    患者呈现腹水及明显的脾肿大。

noun

1. accumulation of serous fluid in peritoneal cavity